From Preclinical to Proof of Concept: FIH Challenges episode artwork

EPISODE · Feb 20, 2026 · 39 MIN

From Preclinical to Proof of Concept: FIH Challenges

from Regulatory: The Emerging C-Suite Leader · host SSI Strategy

Gilmore O’Neill, neurologist and CEO of Editas, unpacks what strong regulatory leadership looks like when a biotech is racing toward first-in-human (FIH) and proof of concept.

Gilmore O’Neill, neurologist and CEO of Editas, unpacks what strong regulatory leadership looks like when a biotech is racing toward first-in-human (FIH) and proof of concept.

NOW PLAYING

From Preclinical to Proof of Concept: FIH Challenges

0:00 39:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Regulatory: The Emerging C-Suite Leader?

This episode is 39 minutes long.

When was this Regulatory: The Emerging C-Suite Leader episode published?

This episode was published on February 20, 2026.

What is this episode about?

Gilmore O’Neill, neurologist and CEO of Editas, unpacks what strong regulatory leadership looks like when a biotech is racing toward first-in-human (FIH) and proof of concept.

Can I download this Regulatory: The Emerging C-Suite Leader episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!